Instead, in an animal model, hair shaft elongation was promoted by NTAPP exposure on the mouse back skin, and NTAPP induced the telogen-anagen transition and increased length and thickness of HFs
NICE guidance (NG28) supports stepwise diabetes treatment with one incretin-based therapy at a time
doi: 10.1519/JSC.0b013e3182a76790.The effects of acute L-carnitine supplementation on endurance performance of athletes
It may be that we should continue treatment in people who have had cardiovascular disease, even if they dont lose as much weight as we would like. This is already the case in the United States where, in March 2024, the US Food and Drug Administration approved Wegovy to treat adults with cardiovascular disease who also have obesity or are overweight but without diabetes mellitus
instead, it may help provide context for provider conversations about whether a microdose protocol, standard dosing, or an alternative compound might align with your genetic pathway profile